Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Prepaid Assets (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Prepaid Assets for 9 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 1454.55% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2025, up 1454.55% year-over-year, with the annual reading at $10.1 million for FY2025, 1454.55% up from the prior year.
  • Prepaid Assets hit $10.1 million in Q4 2025 for Protagonist Therapeutics, up from $742000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $10.1 million in Q4 2025 to a low of $65000.0 in Q3 2023.
  • Historically, Prepaid Assets has averaged $3.6 million across 5 years, with a median of $1.4 million in 2022.
  • Biggest five-year swings in Prepaid Assets: tumbled 99.28% in 2023 and later soared 1454.55% in 2025.
  • Year by year, Prepaid Assets stood at $1.7 million in 2021, then dropped by 18.84% to $1.4 million in 2022, then fell by 26.61% to $1.0 million in 2023, then tumbled by 37.6% to $649000.0 in 2024, then skyrocketed by 1454.55% to $10.1 million in 2025.
  • Business Quant data shows Prepaid Assets for PTGX at $10.1 million in Q4 2025, $742000.0 in Q3 2025, and $884000.0 in Q2 2025.